Effects of Raloxifene on the Proliferation and Apoptosis of Human Aortic Valve Interstitial Cells

BioMed Research International

Volumn 2016, Issue , 2016, Pages

  Fu, Zhimin ^a,b   Luo, Bin ^c   Li, Mingpeng ^b   Peng, Bin ^b   Wang, Zheng ^a,c  

^a JINAN UNIVERSITY   (China)

^b Chenzhou First People's Hospital of Hunan Province   (China)

^c SHENZHEN PEOPLE'S HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CASPASE 8; RALOXIFENE; CASP3 PROTEIN, HUMAN; CASP8 PROTEIN, HUMAN;

ADULT; AORTA VALVE; AORTIC VALVE INTERSTITIAL CELL; APOPTOSIS; ARTICLE; CELL CYCLE; CELL PROLIFERATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG MECHANISM; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MIDDLE AGED; NORMAL HUMAN; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VASCULAR ENDOTHELIAL CELL; WESTERN BLOTTING; BIOSYNTHESIS; CELL CULTURE; CYTOLOGY; DRUG EFFECTS; ENZYMOLOGY; GENE EXPRESSION REGULATION; TIME FACTOR;

AORTIC VALVE; APOPTOSIS; CASPASE 3; CASPASE 8; CELL PROLIFERATION; CELLS, CULTURED; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; MIDDLE AGED; RALOXIFENE HYDROCHLORIDE; TIME FACTORS;

EID: 85003794212     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2016/5473204     Document Type: Article

References (26)

1. E. Eren, H. Y. Ellidag, Y. Cekin, R. U. Ayoglu, A. O. Sekercioglu, and N. Yilmaz, "Heart valve disease: the role of calcidiol deficiency, elevated parathyroid hormone levels and oxidative stress in mitral and aortic valve insufficiency, " Redox Report, vol. 19, no. 1, pp. 34-39, 2014.
2. C. J. Talluto and N. H. Silverman, "Aortic and mitral valve stenosis with regurgitation: not due to rheumatic heart disease, " Echocardiography, vol. 28, no. 2, pp. E24-E27, 2011.
3. N. Venardos, N. A. Nadlonek, Q. Zhan et al., "Aortic valve calcification ismediated by a differential response of aortic valve interstitial cells to inflammation, " Journal of Surgical Research, vol. 190, no. 1, pp. 1-8, 2014.
4. E. Barrett-Connor, L. Mosca, P. Collins et al., "Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women, "The New England Journal ofMedicine, vol. 355, no. 2, pp. 125-137, 2006.
5. D. E. Kim, Y. Kim, D.-H. Cho et al., "Raloxifene induces autophagy-dependent cell death in breast cancer cells via the activation of amp-activated protein kinase, "Molecules and Cells, vol. 38, no. 2, pp. 138-144, 2015.
6. E. Seli, T. Pehlivan, B. Selam, J. A. Garcia-Velasco, and A. Arici, "Estradiol down-regulates MCP-1 expression in human coronary artery endothelial cells, " Fertility and Sterility, vol. 77, no. 3, pp. 542-547, 2002.
7. M.-T. Chung, P.-Y. Cheng, K.-K. Lam et al., "Cardioprotective effects of long-term treatment with raloxifene, a selective estrogen receptor modulator, on myocardial ischemia/reperfusion injury in ovariectomized rats, " Menopause, vol. 17, no. 1, pp. 127-134, 2010.
8. K. S. Stamatelopoulos, J. P. Lekakis, N. A. Poulakaki et al., "Tamoxifen improves endothelial function and reduces carotid intima-media thickness in postmenopausal women, " American Heart Journal, vol. 147, no. 6, pp. 1093-1099, 2004.
9. D. L. Mulholland and A. I. Gotlieb, "Cell biology of valvular interstitial cells, "TheCanadian Journal of Cardiology, vol. 12, no. 3, pp. 231-236, 1996.
10. R. Rosenhek, T. Binder, G. Porenta et al., "Predictors of outcome in severe, asymptomatic aortic stenosis, " The New England Journal of Medicine, vol. 343, no. 9, pp. 611-617, 2000.
11. A. Vamvakidou, N. Karogiannis, I. Ramzy, A. Elghamaz, and R. Senior, "Exercise echocardiography in asymptomatic severe aortic stenosis, " The International Journal of Cardiovascular Imaging, vol. 31, no. 8, pp. 1561-1562, 2015.
12. X. Gu and K. S. Masters, "Role of the Rho pathway in regulating valvular interstitial cell phenotype and nodule formation, " American Journal of Physiology-Heart and Circulatory Physiology, vol. 300, no. 2, pp. H448-H458, 2011.
13. A. Kumar, D. C. Wiltz, and K. J. Grande-Allen, "Gentamicin reduces calcific nodule formation by aortic valve interstitial cells in vitro, " Cardiovascular Engineering and Technology, vol. 4, no. 1, pp. 16-25, 2013.
14. N. M. Rajamannan, G. Sangiorgi, M. Springett et al., "Experimental hypercholesterolemia induces apoptosis in the aortic valve, " Journal of Heart Valve Disease, vol. 10, no. 3, pp. 371-374, 2001.
15. Y. Chu, D. D. Lund, R. M. Weiss et al., "Pioglitazone attenuates valvular calcification induced by hypercholesterolemia, " Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 33, no. 3, pp. 523-532, 2013.
16. B. Jian, N. Narula, Q.-Y. Li, E. R. Mohler III, and R. J. Levy, "Progression of aortic valve stenosis: TGF-β1 is present in calcified aortic valve cusps and promotes aortic valve interstitial cell calcification via apoptosis, " Annals ofThoracic Surgery, vol. 75, no. 2, pp. 457-465, 2003.
17. J. H. Pickar and B. S. Komm, "Selective estrogen receptor modulators and the combination therapy conjugated estrogens/ bazedoxifene: a review of effects on the breast, " Post Reproductive Health, vol. 21, no. 3, pp. 112-121, 2015.
18. C. Meier, O. Lamy, M.-A. Krieg et al., "The role of teriparatide in sequential and combination therapy of osteoporosis, " Swiss MedicalWeekly, vol. 144, Article IDw13952, 2014.
19. A. Z. Lamas, I. F. Caliman, P. L. M. Dalpiaz et al., "Comparative effects of estrogen, raloxifene and tamoxifen on endothelial dysfunction, inflammatory markers and oxidative stress in ovariectomized rats, " Life Sciences, vol. 124, pp. 101-109, 2015.
20. H. Sumino, S. Ichikawa, S. Kasama et al., "Effects of raloxifene on brachial arterial endothelial function, carotid wall thickness, and arterial stiffness in osteoporotic postmenopausal women, " International Heart Journal, vol. 51, no. 1, pp. 60-67, 2010.
21. M. R. Meyer, E. R. Prossnitz, and M. Barton, "The G proteincoupled estrogen receptor GPER/GPR30 as a regulator of cardiovascular function, " Vascular Pharmacology, vol. 55, no. 1-3, pp. 17-25, 2011.
22. M. Poirot, S. Silvente-Poirot, and R. R. Weichselbaum, "Cholesterolmetabolismand resistance to tamoxifen, " Current Opinion in Pharmacology, vol. 12, no. 6, pp. 683-689, 2012.
23. M. Shuvy, S. Abedat, R. Beeri et al., "Raloxifene attenuates Gas6 and apoptosis in experimental aortic valve disease in renal failure, " American Journal of Physiology-Heart and Circulatory Physiology, vol. 300, no. 5, pp. H1829-H1840, 2011.
24. B. Payré, P. de Medina, N. Boubekeur et al., "Microsomal antiestrogen-binding site ligands induce growth control and differentiation of human breast cancer cells through the modulation of cholesterol metabolism, " Molecular Cancer Therapeutics, vol. 7, no. 12, pp. 3707-3718, 2008.
25. P. de Medina, B. Payré, N. Boubekeur et al., "Ligands of the antiestrogen-binding site induce active cell death and autophagy in human breast cancer cells through themodulation of cholesterol metabolism, " Cell Death and Differentiation, vol. 16, no. 10, pp. 1372-1384, 2009.
26. P. De Medina, M. R. Paillasse, G. Ségala et al., "Importance of cholesterol and oxysterols metabolism in the pharmacology of tamoxifen and other AEBS ligands, " Chemistry and Physics of Lipids, vol. 164, no. 6, pp. 432-437, 2011.